Nuclear Medicine and Biology
Volume 36, Issue 6 , Pages 631-641 , August 2009

Synthesis, 68Ga labeling and preliminary evaluation of DOTA peptide binding vascular adhesion protein-1: a potential PET imaging agent for diagnosing osteomyelitis

  • Tiina Ujula

      Affiliations

    • Turku PET Center, Turku University Hospital, Turku, Finland
  • ,
  • Satu Salomäki

      Affiliations

    • Turku PET Center, Turku University Hospital, Turku, Finland
    • Department of Chemistry, University of Turku, Turku, Finland
  • ,
  • Pauliina Virsu

      Affiliations

    • Turku PET Center, Turku University Hospital, Turku, Finland
  • ,
  • Petteri Lankinen

      Affiliations

    • Orthopedic Research Unit, University of Turku, Turku, Finland
  • ,
  • Tatu J. Mäkinen

      Affiliations

    • Orthopedic Research Unit, University of Turku, Turku, Finland
  • ,
  • Anu Autio

      Affiliations

    • Turku PET Center, Turku University Hospital, Turku, Finland
  • ,
  • Gennady G. Yegutkin

      Affiliations

    • MediCity Research Laboratory, University of Turku, Turku, Finland
  • ,
  • Juhani Knuuti

      Affiliations

    • Turku PET Center, Turku University Hospital, Turku, Finland
  • ,
  • Sirpa Jalkanen

      Affiliations

    • MediCity Research Laboratory, University of Turku, Turku, Finland
    • National Public Health Institute, Turku, Finland
  • ,
  • Anne Roivainen

      Affiliations

    • Turku PET Center, Turku University Hospital, Turku, Finland
    • Turku Center for Disease Modeling, University of Turku, Turku, Finland
    • Corresponding Author InformationCorresponding author. Turku PET Center, Turku University Hospital, FI-20521 Turku, Finland. Tel.: +358 2 3132862; fax: +358 2 2318191.

Received 23 February 2009 ,Revised 18 March 2009 ,Accepted 6 April 2009.

References 

  1. Rennen HJ, Boerman OC, Oyen WJ, Corstens FH. Imaging infection/inflammation in the new millennium. Eur J Nucl Med. 2001;28:241–252
  2. Signore A, Capriotti G, Scopinaro F, Bonanno E, Modesti A. Radiolabelled lymphokines and growth factors for in vivo imaging of inflammation, infection and cancer. Trends Immunol. 2003;24:395–402
  3. Nibbering PH, Welling MM, Paulusma-Annema A, Brouwer CP, Lupetti A, Pauwels EK. 99mTc-labeled UBI 29-41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus. J Nucl Med. 2004;45:321–326
  4. Langer O, Brunner M, Zeitlinger M, Ziegler S, Müller U, Dobrozemsky G, et al. In vitro and in vivo evaluation of [18F]ciprofloxacin for the imaging of bacterial infections with PET. Eur J Nucl Med Mol Imaging. 2005;32:143–150
  5. van Eerd JE, Oyen WJ, Harris TD, Rennen HJ, Edwards DS, Corstens FH, et al. Scintigraphic imaging of infectious foci with an 111In-LTB4 antagonist is based on in vivo labeling of granulocytes. J Nucl Med. 2005;46:786–793
  6. Mattner F, Katsifis A, Staykova M, Ballantyne P, Willenborg DO. Evaluation of a radiolabelled peripheral benzodiazepine receptor ligand in the central nervous system inflammation of experimental autoimmune encephalomyelitis: a possible probe for imaging multiple sclerosis. Eur J Nucl Med Mol Imaging. 2005;32:557–563
  7. Palestro CJ. In vivo leukocyte labeling: the quest continues. J Nucl Med. 2007;48:332–334
  8. McPhee E, Eskander JP, Eskander MS, Mahan ST, Mortimer E. Imaging in pelvic osteomyelitis, support for early magnetic resonance imaging. J Pediatr Orthop. 2007;27:903–909
  9. Salmi M, Jalkanen S. A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. Science. 1992;257:1407–1409
  10. Salmi M, Tohka S, Berg EL, Butcher EC, Jalkanen S. Vascular adhesion protein 1 (VAP-1) mediates lymphocyte subtype-specific, selectin-independent recognition of vascular endothelium in human lymph nodes. J Exp Med. 1997;186:589–600
  11. Salmi M, Jalkanen S. VAP-1: an adhesin and an enzyme. Trends Immunol. 2001;22:211–216
  12. Merinen M, Irjala H, Salmi M, Jaakkola I, Hänninen A, Jalkanen S. Vascular adhesion protein-1 is involved in both acute and chronic inflammation in the mouse. Am J Pathol. 2005;166:793–800
  13. Salmi M, Kalimo K, Jalkanen S. Induction and function of vascular adhesion protein-1 at sites of inflammation. J Exp Med. 1993;178:2255–2260
  14. Marttila-Ichihara F, Smith DJ, Stolen C, Yegutkin GG, Elima K, Mercier N. Vascular amine oxidases are needed for leukocyte extravasation into inflamed joints in vivo. Arthritis Rheum. 2006;54:2852–2862
  15. Salmi M, Yegutkin GG, Lehvonen R, Koskinen K, Salminen T, Jalkanen S. A cell surface amine oxidase directly controls lymphocyte migration. Immunity. 2001;14:265–276
  16. Kurkijärvi R, Yegutkin GG, Gunson BK, Jalkanen S, Salmi M, Adams DH. Circulating soluble vascular adhesion protein 1 accounts for the increased serum monoamine oxidase activity in chronic liver disease. Gastroenterology. 2000;119:1096–1103
  17. Stolen CM, Marttila-Ichihara F, Koskinen K, Yegutkin GG, Turja R, Bono P, et al. Absence of the endothelial oxidase AOC3 leads to abnormal leukocyte traffic in vivo. Immunity. 2005;22:105–115
  18. Zorzano A, Abella A, Marti L, Carpene C, Palacin M, Testar X. Semicarbazide-sensitive amine oxidase activity exerts insulin-like effects on glucose metabolism and insulin-signaling pathways in adipose cells. Biochim Biophys Acta. 2003;1647:3–9
  19. Bono P, Salmi M, Smith DJ, Jalkanen S. Cloning and characterization of mouse vascular adhesion protein-1 reveals a novel molecule with enzymatic activity. J Immunol. 1998;160:5563–5571
  20. Salmi M, Jalkanen S. Cell-surface enzymes in control of leukocyte trafficking. Nat Rev Immunol. 2005;5:760–771
  21. Gokturk C, Garpenstrand H, Nilsson J, Nordquist J, Oreland L, Forsberg-Nilsson K. Studies on semicarbazide-sensitive amine oxidase in patients with diabetes mellitus and in transgenic mice. Biochim Biophys Acta. 2003;1647:88–91
  22. Lankinen P, Mäkinen TJ, Pöyhönen TA, Virsu P, Salomäki S, Hakanen AJ, et al. 68Ga-DOTAVAP-P1 PET imaging capable of demonstrating the phase of inflammation in healing bones and the progress of infection in osteomyelitic bones. Eur J Nucl Med Mol Imaging. 2008;35:352–364
  23. Yegutkin GG, Salminen T, Koskinen K, Jalkanen S, Salmi M. A peptide inhibitor of vascular adhesion protein-1 (VAP-1) blocks leukocyte–endothelium interactions under shear stress. Eur J Immunol. 2004;34:2276–2285
  24. Wienhard K, Schmand M, Casey ME, Baker K, Bao J, Eriksson L, et al. The ECAT HRRT: performance and first clinical application of the new high resolution research tomography. IEEE Trans Nucl Sci. 2002;49:104–110
  25. O'Reilly T, Mader JT. Rat model of bacterial osteomyelitis of the tibia. In:  Zak O,  Sande MA editor. Handbook of animal models of infection. Bath, Avon, UK: Academic Press; 1999;p. 561–575
  26. Mäkinen TJ, Lankinen P, Pöyhönen T, Jalava J, Aro HT, Roivainen A. Comparison of 18F-FDG and 68Ga PET imaging in the assessment of experimental osteomyelitis due to Staphylococcus aureus. Eur J Nucl Med Mol Imaging. 2005;32:1259–1268
  27. DeGrado TR, Turkington TG, Williams JJ, Stearns CW, Hoffman JM, Coleman RE. Performance characteristics of a whole-body PET scanner. J Nucl Med. 1994;35:1398–1406
  28. Hamacher K, Coenen HH, Stocklin G. Efficient stereospecific synthesis of no-carrier-added 2-18F-fluoro-2-deoxy-d-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med. 1986;27:235–258
  29. Smith DJ, Salmi M, Bono P, Hellman J, Leu T, Jalkanen S. Cloning of vascular adhesion protein 1 reveals a novel multifunctional adhesion molecule. J Exp Med. 1998;188:17–27
  30. Jaakkola K, Nikula T, Holopainen R, Vähäsilta T, Matikainen MT, Laukkanen ML, et al. In vivo detection of vascular adhesion protein-1 in experimental inflammation. Am J Pathol. 2000;157:463–471
  31. Autio A, Haukkala J, Henttinen T, Virsu P, Pöyhönen T, Maksimow M, et al. Effects of PEGylation to the stability of 68Ga-DOTA-peptides for VAP-1 targeting. Eur J Nucl Med Mol Imaging. 2008;35:S389;[abstract = P777]

PII: S0969-8051(09)00114-0

doi: 10.1016/j.nucmedbio.2009.04.008

Nuclear Medicine and Biology
Volume 36, Issue 6 , Pages 631-641 , August 2009